Invesaro

Stocks Health care PHGE

NYSE · Health care

BiomX Inc. (PHGE)

It posted a net loss of $45.5M. In fiscal 2025 capital spending exceeded operating cash flow by $26.4M. At June 30, 2026 it held $347K in cash against $247K of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.

Price
$1.85
+14.20% on the day · September 10, 2026
52-week range $0.49 to $2.16
Market cap
$49.1M
P/E
0.1
on FY2025 diluted EPS

What BiomX Inc. does

BiomX Inc. is registered with the SEC under industry code SIC 7372 (Services-Prepackaged Software). Its shares trade on NYSE under the ticker PHGE.

Revenue and profit by year

Net income
FY19: $347.4K $347.4K FY19FY19: -$20.6M -$20.6M FY19FY20: -$30.1M -$30.1M FY20FY21: -$36.2M -$36.2M FY21FY22: -$28.3M -$28.3M FY22FY23: -$26.2M -$26.2M FY23FY24: -$17.7M -$17.7M FY24FY25: -$36.2M -$36.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$41.5M-$36.2M$22.19-$26.4M
2024n/a-$44.5M-$17.7M$58.31-$37M
2023n/a-$25.3M-$26.2M$88.51-$21.3M
2022n/a-$27.2M-$28.3M$164.86-$29.2M
2021n/a-$35.5M-$36.2M$241.22-$31.3M
2020n/a-$30.3M-$30.1M$225.60-$25.5M

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What BiomX Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 25, 2026
  2. September 22, 2026
  3. September 17, 2026
  4. September 15, 2026
  5. September 9, 2026
  6. September 1, 2026
  7. September 1, 2026
  8. August 28, 2026
  9. August 25, 2026
  10. August 20, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on March 18, 2026. Insider transactions on SEC

Who owns PHGE

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Nantahala Capital Management, LLC13G, passive with 2 related filers 7.13% 730,551 August 14, 2026

Latest filings below 5%: Mayers Ventures LLC 4.86% (September 17, 2026); Cystic Fibrosis Foundation 1.5% (August 20, 2026); Rodney Hodges 0.7% (August 13, 2026); Deerfield Management Company, L.P. 4.7% (June 16, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PHGE

What does BiomX Inc. do?

BiomX Inc. is registered with the SEC under industry code SIC 7372 (Services-Prepackaged Software). Its shares trade on NYSE under the ticker PHGE.

Is BiomX Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $45.5M.

When did BiomX Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 25, 2026.

Similar companies

Compare PHGE with

Compare PHGE with any company

Follow PHGE

Get an email when BiomX Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PHGE: get an email when it files

Where the numbers come from

Financial figures are the values BiomX Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.